Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Europe
1 - 3 June, 2027
Congress CenterBasel Switzerland

Dr. Stian Foss, PhD
Researcher at Oslo University Hospital
Speaker

Profile

I am a researcher in the Laboratory of Adaptive Immunity and Homeostasis at the University of Oslo, led by Professor Jan Terje Andersen. My research focuses on the interplay between antibodies and their cellular receptors, such as the neonatal Fc receptor (FcRn) and the cytosolic Fc receptor tripartite motif-containing 21 (TRIM21). By combining structural and biophysical approaches with biochemical, cellular, and in vivo experiments, knowledge from this basic research is used to inform innovative design of antibody molecules with improved functions and tailored modes of action. I am currently funded by the Research Council of Norway through its Young Research Talents program.

Agenda Sessions

  • Distinct Effects of IgG1 Fc Engineering for FcRn Mediated Half-life Extension on TRIM21 Engagement and Activity

    17:25